Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Date: March 17, 2026
Context: This filing incorporates by reference a press release dated March 17, 2026, announcing the Company's 2025 Full Year Financial and Operational Results.
Key Financial Metrics
The provided Form 6-K text serves as a cover document and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, no specific financial metrics can be extracted from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only indicates that the Company has reported its full-year results for 2025.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. These elements are presumed to be within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the actual 2025 full-year financial figures.
- Verify the specific revenue and net loss numbers reported in the press release.
- Check the press release for any updates on clinical trial progress or regulatory approvals.
- Confirm the Company's cash position and runway as stated in the full report.
- Review the "Forward-Looking Statements" section in the press release for updated guidance.